ITGAX and neoplasm: Therefore, to determine how the local immunity could be impacted following tumor debulking over time, we used a double transgenic LysM-EGFP/CD11c-EYFP C57BL/6 reporter mice [26] fluorescent for blood-derived myeloid cells and microglia.